-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
PD 134922
Category | HIV Protease |
CAS | 150351-30-7 |
Description | PD 134922 has been found to be a HIV-1 protease inhibitor that could probably be effective against HIV infections. |
Product Information
Synonyms | PD 134922;150351-30-7;(2S,4S,5S)-N-butyl-6-cyclohexyl-4-hydroxy-5-[[(2S)-2-[[(2S)-2-(morpholin-4-ylsulfonylamino)-3-phenylpropanoyl]amino]pent-4-enoyl]amino]-2-propan-2-ylhexanamide;(2S,4S,5S)-N-butyl-6-cyclohexyl-4-hydroxy-2-isopropyl-5-((S)-2-((S)-2-(morpholine-4-sulfonamido)-3-phenylpropanamido)pent-4-enamido)hexanamide;PD-134922;DTXSID30164523;DA-76649;HY-123415;CS-0082632;(2S)-2-{(2S)-2-[(morpholin-4-ylsulfonyl)amino]-3-phenylpropanoylamino}-N-[(1S,2S,4S)-4-(N-butylcarbamoyl)-1-(cyclohexylmethyl)-2-hydroxy-5-methylhexyl]pent-4-enamide;(2S,4S,5S)-N-butyl-6-cyclohexyl-4-hydroxy-2-isopropyl-5-[[(2S)-2-[[(2S)-2-(morpholinosulfonylamino)-3-phenyl-propanoyl]amino]pent-4-enoyl]amino]hexanamide;L-Norvalinamide, N-(4-morpholinylsulfonyl)-L-phenylalanyl-N-(4-((butylamino)carbonyl)-1-(cyclohexylmethyl)-2-hydroxy-5-methylhexyl)-4,5-didehydro-, (1S-(1R*,2R*,4R*))-; |
IUPAC Name | (2S,4S,5S)-N-butyl-6-cyclohexyl-4-hydroxy-5-[[(2S)-2-[[(2S)-2-(morpholin-4-ylsulfonylamino)-3-phenylpropanoyl]amino]pent-4-enoyl]amino]-2-propan-2-ylhexanamide |
Molecular Weight | 719.97 |
Molecular Formula | C37H61N5O7S |
Canonical SMILES | CCCCNC([C@H](C(C)C)C[C@H](O)[C@@H](NC([C@@H](NC([C@@H](NS(=O)(N1CCOCC1)=O)CC2=CC=CC=C2)=O)CC=C)=O)CC3CCCCC3)=O |
InChI | InChI=1S/C37H61N5O7S/c1-5-7-19-38-35(44)30(27(3)4)26-34(43)32(24-28-15-10-8-11-16-28)40-36(45)31(14-6-2)39-37(46)33(25-29-17-12-9-13-18-29)41-50(47,48)42-20-22-49-23-21-42/h6,9,12-13,17-18,27-28,30-34,41,43H,2,5,7-8,10-11,14-16,19-26H2,1,3-4H3,(H,38,44)(H,39,46)(H,40,45)/t30-,31-,32-,33-,34-/m0/s1 |
InChIKey | VIPMITURFYCOES-LJADHVKFSA-N |
Purity | 98% |
Appearance | Powder |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |